Researchers reveal that for early breast cancer a single dose of targeted intraoperative radiotherapy (TARGIT-IORT) is as effective at preventing breast cancer recurrence as the standard of care.
A breast cancer therapy developed by UCL clinicians which requires just one shot of radiotherapy compared to the weeks-long treatment of current therapies been shown to be effective for most women.